Cleveland Clinic and Novo Nordisk Foundation announced a recent academic partnership focused on cutting-edge computer science research and its clinical applications. The three-year opportunity is open to early-stage researchers working at the intersection of quantum technologies, artificial intelligence, and precision medicine.
WHY IS THIS IMPORTANT
Quantum sensors and AI-powered analytics could improve diagnostics by increasing accuracy and reducing time to diagnosis, according to a statement from the health system and foundation released Monday.
Over the next three years, NNF will provide up to $6.2 million in research funding to 12 scientists at both institutions in diagnostics, drug discovery, personalized medicine and other areas.
Dr. Lara Jehi, chief research information officer at the Cleveland Clinic, said in a statement that the fellowship program collaboration is part of an effort to support future biomedical researchers who can apply data and technology to benefit patients and science.
“By combining our strengths, we aim to accelerate the implementation of quantum technologies and artificial intelligence in clinical settings, promoting a new era of medical innovation that draws on the best of both our institutions,” she said.
Researchers will also be offered industrial internships.
The health system and foundation said in a statement Monday that they will encourage researchers to consider three- to six-month industrial internships to gain hands-on experience and explore opportunities to develop market-ready applications.
While in Cleveland, fellows will also have the opportunity to collaborate with IBM scientists who are already working with the health system through the Discovery Accelerator program.
BIGGER TREND
Because creating quantum computing algorithms can assist solve healthcare problems, startups are collaborating with scientists and researchers at the Cleveland Clinic as part of the Clinic Quantum Innovation Catalyzer Program.
Similarly, health systems are using AI to transform care and improve patient outcomes, which is generating a lot of interest, Dr. Carrie Nelson, chief medical officer of telemedicine technology and services company Amwell, said last year.
Using AI comes with risks, and health care needs to strengthen data models “if AI is to live up to its potential to help health care providers improve care,” she said. “More experience with AI-enabled care models will be needed to discover what is possible, what is not, and how to establish the right guardrails.”
IN THE DOCUMENT
“The collaboration between NNF and Cleveland Clinic aims to enable the use of critical advanced technologies, such as quantum technology and artificial intelligence, in biomedical research and clinical applications, ensuring that these innovative technologies advance our understanding of disease and improve patient outcomes,” said Lene Oddershede, NNF senior vice president and head of life sciences and engineering.
The HIMSS AI in Healthcare Forum will be held September 5-6 in Boston. Learn more and sign up.